| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0427 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3693 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
| filingDate |
2002-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59d09b7a05424cdbf349b0e2539b8eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6a3069b244bd9971449c2f72dd37dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367bce30ae43eb74e982c12479517d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b979daf23b3446b8a479a5839db3d10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ba571f4282ab54d862ecc3ab4c7eb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b403efe0372833a8ba9cf0e02509516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca205fd96a85751616bbd90f8d261a7 |
| publicationDate |
2004-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1420833-A2 |
| titleOfInvention |
System for the production of autologous platelet |
| abstract |
A centrifuge system is disclosed for the formation of an autologous platelet gel wherein all of the blood components for the gel are derived from a patient to whom the gel is to be applied. First a platelet rich plasma and a platelet poor plasma are formed by centrifuging a quantity of anticoagulated whole blood that was previously drawn from the patient. The platelet rich plasma or platelet poor plasma is then automatically drawn out of the centrifuge bag and proportioned into separate chambers in a dispenser. The first portion is activated where a clot is formed and thrombin is obtained. The thrombin is then latter mixed with the second portion to obtain a platelet gel. Delivery systems are mentioned. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014194930-A1 |
| priorityDate |
2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |